When will the FDA reclassify BPC 157 to Category 1? Odds & Predictions 2026 FDA Peptide Reclassification Purefico Medspa and Therapy BPC 157 FDA Approval Status 2026: RFK Jr, Advisory Committee & Reclassification Peptide access could look very different after 2026. The FDA and its Pharmacy Compounding Advisory Committee (PCAC) are reviewing popular peptides like BPC 157, TB 500, and MOTS C. This isn't about validating every health The FDA just changed the game for peptides. April 2026 The FDA is reviewing Category 2 peptides for potential removal from restricted status. Full approval for some peptides may be